Strides Pharma Science Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Strides Pharma Science Limited Pharmaceutical Export Portfolio Dataset — 42 Products, $179.3M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Strides Pharma Science Limited — Pharmaceutical Exporter Profile (2026) | 42 Products, $179.3M Trade | TransData Nexus

Strides Pharma Science Limited

Indian Pharmaceutical Exporter · Analgesics & Antipyretics Specialist · $179.3M Total Trade · DGFT Verified

Strides Pharma Science Limited is an Indian pharmaceutical exporter with a total trade value of $179.3M across 42 products in 20 therapeutic categories. Based on 4,091 verified export shipments from Indian Customs (DGFT) records, Strides Pharma Science Limited is the #1 Indian exporter in 8 products including Rosuvastatin, Prednisone, Prednisolone. Top exports include Ibuprofen ($24.2M), Rosuvastatin ($21.0M), Gabapentin ($14.9M).

Strides Pharma Science Limited — Export Portfolio & Destination Treemap

Strides Pharma Science Limited pharmaceutical export portfolio — 42 products across 20 therapeutic categories. Source: Indian Customs (DGFT).

Who is Strides Pharma Science Limited? — Company Overview & Market Position

Strides Pharma Science Limited, established in 1990, is a prominent Indian pharmaceutical company headquartered in Bengaluru, Karnataka. The company specializes in the development and manufacturing of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. In July 2018, Strides Shasun Limited rebranded itself as Strides Pharma Science Limited to better reflect its global presence and diversified portfolio.

As of March 2026, Strides Pharma Science Limited reported a total export value of $179.3 million USD, with 4,091 shipments across 42 products spanning 20 therapeutic categories. The company's product portfolio is notably concentrated, with the top five products—Rosuvastatin, Vancomycin, Gabapentin, Prednisone, and Ibuprofen—accounting for 45.3% of total exports. Prednisone leads with a 36.0% market share, while Rosuvastatin holds a 4.5% share.

What Does Strides Pharma Science Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Ibuprofen$24.2M 2

Product Portfolio — Top 30 by Export Value

Strides Pharma Science Limited exports 42 pharmaceutical products across 20 therapeutic categories. Market leader (#1 exporter) in 8 products.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Ibuprofen	Analgesics & Antipyretics	$24.2M	484	4.1%	5
2	Rosuvastatin	Cardiovascular	$21.0M	420	4.5%	1
3	Gabapentin	CNS & Psychiatric	$14.9M	299	1.7%	3
4	Vancomycin	Antibiotics	$11.0M	220	11.9%	2
5	Prednisone	Respiratory	$10.1M	201	36.0%	1
6	Mycophenolate	Immunosuppressants	$9.7M	193	2.9%	2
7	Iron	Vitamins & Supplements	$9.4M	225	1.9%	9
8	Artemether	Antimalarial & Antiparasitic	$8.3M	167	0.9%	5
9	Prednisolone	Respiratory	$5.8M	116	6.0%	1
10	Hydrocortisone	Corticosteroids	$5.8M	115	8.8%	1
11	Magnesium	Vitamins & Supplements	$5.0M	100	1.4%	6
12	Doxycycline	Antibiotics	$4.5M	127	3.8%	6
13	Natural	Ayurvedic & Herbal Products	$4.0M	115	15.8%	2
14	Tenofovir	Antiviral & HIV Medications	$3.8M	75	0.1%	4
15	Tacrolimus	Immunosuppressants	$3.5M	69	1.7%	8
16	Oseltamivir	Antivirals	$3.3M	66	2.7%	4
17	Quinine	Antimalarial & Antiparasitic	$3.1M	63	16.3%	1
18	Cyclosporine	Immunosuppressants	$3.1M	62	25.5%	1
19	Celecoxib	Analgesics & Antipyretics	$2.8M	92	2.1%	10
20	Folic	Nutritional Supplements	$2.8M	86	4.9%	3
21	Omega	Nutritional Supplements	$2.6M	53	14.0%	1
22	Acarbose	Advanced Diabetes Medications	$2.5M	51	37.8%	1
23	Vitamin	Nutritional Supplements	$2.5M	71	1.7%	8
24	Pravastatin	Cardiovascular	$2.3M	111	7.5%	5
25	Dolutegravir	Antiviral & HIV Medications	$1.9M	39	0.0%	5
26	Loperamide	Gastrointestinal	$1.9M	39	2.6%	3
27	Ketoconazole	Antifungals	$1.4M	28	3.5%	3
28	Colchicine	Lipid & Metabolism	$1.3M	30	6.2%	4
29	Atenolol	Cardiovascular	$1.3M	82	3.1%	8
30	Meloxicam	Analgesics & Antipyretics	$781.6K	73	0.4%	11

Strides Pharma Science Limited exports 42 pharmaceutical products across 20 therapeutic categories with a total export value of $179.3M. The company is the #1 Indian exporter in 8 products: Rosuvastatin, Prednisone, Prednisolone, Hydrocortisone, Quinine and 3 more. The top category is Analgesics & Antipyretics (15.5% of portfolio), followed by Cardiovascular (14.2%), reflecting a diversified portfolio where the top 5 products account for only 45.3% of total value.

Showing top 30 of 42 products. Contact us for complete data.

Strides Pharma Science Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Strides Pharma Science Limited operates a global manufacturing footprint with eight facilities across four continents. In India, the company has multiple plants, including those in Bengaluru, Chennai, and Puducherry, which produce a range of dosage forms such as soft and hard gelatin capsules, tablets, and injectables. Internationally, Strides owns Beltapharm S.R.L. in Italy, enhancing its European presence.

3Key Leadership

The leadership team at Strides Pharma Science Limited is headed by Managing Director and CEO Badree Komandur, who has been instrumental in steering the company's strategic direction. Vikesh Kumar serves as the Chief Financial Officer, overseeing financial operations and investor relations. Other key executives include P. V. S. Ramaraju, the Chief Operating Officer, and Aditya Arun Kumar, the Executive Director of Business Development.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Strides Pharma Science Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Strides Pharma Science Limited has established a significant presence in regulated markets, including the United States, Europe, the United Kingdom, Australia, and Japan. The company operates five US FDA-approved facilities, ensuring compliance with stringent regulatory standards. In Europe, Strides owns Beltapharm S.R.L. in Italy, enhancing its market access. The company's commitment to quality and compliance has facilitated its entry into these markets, allowing it to offer a diverse range of pharmaceutical products.

2Emerging Markets

Strides Pharma Science Limited has expanded its footprint in emerging markets, including Africa, Latin America, and Southeast Asia. The company's partnership with the Clinton Foundation has enabled it to supply lower-cost anti-retroviral drugs for the treatment of HIV/AIDS, demonstrating its commitment to global health initiatives. Additionally, Strides is listed as a WHO pre-qualified supplier, allowing it to participate in global procurement programs for essential medicines.

3Geographic Strategy

Strides Pharma Science Limited's geographic strategy involves a balanced approach, with a strong presence in both regulated and emerging markets. The company's operations in regulated markets provide stability and adherence to stringent quality standards, while its expansion into emerging markets offers growth opportunities and diversification. This strategic diversification mitigates concentration risk and positions Strides to capitalize on global pharmaceutical demand.

Strides Pharma Science Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Strides Pharma Science Limited maintains a robust relationship with the US FDA, operating five FDA-approved facilities. The company has a history of successful ANDA (Abbreviated New Drug Application) approvals, reflecting its capability to bring generic drugs to the US market. Additionally, Strides has filed multiple DMFs (Drug Master Files), ensuring transparency and compliance with FDA requirements. The company's facilities have undergone FDA inspections, demonstrating adherence to Good Manufacturing Practices (GMP).

2WHO & EU GMP

Strides Pharma Science Limited's commitment to quality is evident through its WHO prequalification status, allowing it to supply essential medicines globally. The company's EU GMP certificates further validate its adherence to European manufacturing standards, facilitating market access in the European Union. These certifications underscore Strides' dedication to maintaining high-quality manufacturing processes across its facilities.

3CDSCO & Indian Regulatory

Strides Pharma Science Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

In the pharmaceutical industry, Strides Pharma Science Limited faces competition from major players such as Sun Pharmaceutical Industries Ltd, Aurobindo Pharma Ltd, and Cipla Ltd. While Strides holds a leading position in certain therapeutic categories, its competitors have a broader product portfolio and larger market share in various segments. Strides' focus on niche and technically complex formulations differentiates it from competitors, allowing it to cater to specialized market needs.

2Key Differentiators

Strides Pharma Science Limited's key differentiators include its specialization in niche and technically complex pharmaceutical formulations, making it one of the world's largest manufacturers of soft gelatin capsules. The company's global manufacturing footprint, with facilities in multiple countries, and its commitment to quality and compliance, as evidenced by its WHO prequalification and EU GMP certifications, further distinguish it in the competitive landscape.

3Strategic Position

Strides Pharma Science Limited's current strategic direction focuses on the development and manufacture of generic pharmaceuticals, with an emphasis on niche and complex formulations. The company's expansion into regulated markets, coupled with its presence in emerging markets, positions it for sustained growth. Future outlooks suggest continued investment in research and development to enhance its product portfolio and maintain a competitive edge in the global pharmaceutical industry.

Buyer Due Diligence Brief — Evaluating Strides Pharma Science Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Strides Pharma Science Limited has a strong track record in the pharmaceutical industry, with consistent export volumes and a diverse product portfolio. The company's adherence to international quality standards, as demonstrated by its various certifications, and its reliable supply chain operations, underscore its reliability as a supplier. Strides' focus on niche and complex formulations further enhances its appeal to partners seeking specialized pharmaceutical products.

2Certifications to Verify

Importers should verify the following certifications when considering Strides Pharma Science Limited as a supplier:

FDA Approval: Confirm the company's facilities are FDA-approved by reviewing the FDA's official database.

WHO-GMP Certification: Verify WHO prequalification status through the WHO's official website.

EU GMP Certification: Check for EU GMP certificates via the European Medicines Agency (EMA) website.

Frequently Asked Questions — Strides Pharma Science Limited

How many pharmaceutical products does Strides Pharma Science Limited export from India?

Strides Pharma Science Limited exports 42 pharmaceutical products across 20 therapeutic categories. The top exports are Ibuprofen ($24.2M), Rosuvastatin ($21.0M), Gabapentin ($14.9M), Vancomycin ($11.0M), Prednisone ($10.1M). Total export value is $179.3M.

What is Strides Pharma Science Limited's total pharmaceutical export value?

Strides Pharma Science Limited's total pharmaceutical export value is $179.3M, based on 4,091 verified shipments recorded in Indian Customs (DGFT) data.

In which products is Strides Pharma Science Limited the #1 Indian exporter?

Strides Pharma Science Limited is the #1 Indian exporter in 8 products: Rosuvastatin (4.5% market share), Prednisone (36.0% market share), Prednisolone (6.0% market share), Hydrocortisone (8.8% market share), Quinine (16.3% market share), Cyclosporine (25.5% market share), Omega (14.0% market share), Acarbose (37.8% market share).

What therapeutic categories does Strides Pharma Science Limited cover?

Strides Pharma Science Limited exports across 20 therapeutic categories. The largest are Analgesics & Antipyretics (15.5%, 3 products), Cardiovascular (14.2%, 4 products), Immunosuppressants (9.1%, 4 products).

Get Full Strides Pharma Science Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.